Jacques Hauert
University of Lausanne
8 Papers
301 Citations
Jacques Hauert is an academic researcher from University of Lausanne. The author has contributed to research in topics: Prekallikrein & Acute leukemia. The author has an hindex of 5, co-authored 8 publications.
Chat about Author
Papers
Necrosis of skin induced by coumarin in a patient deficient in protein S.
TL;DR: Case of skin necrosis induced by coumarin in a patient with functional deficiency of protein S and normal concentrations of protein C is reported.
86
Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.
TL;DR: These studies show that malignant transformation of breast and colon is accompanied by important changes of the production of a UK‐related PA and of an inhibitory activity directed against UK.
85
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
TL;DR: Two different plasmatic plasminogen activators (PA) can be demonstrated after sodium dodecyl sulfate polyacrylamide gel electrophoresis of plasma freshly collected from resting volunteers, followed by transfer of the gels onto plasMinogen-rich fibrin-agarose plates.
High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium
Olivier Spertini,Patrizia Callegari,A.-S. Cordey,Jacques Hauert,Jean Joggi,Vladimir von Fliedner,Marc Schapira +6 more
TL;DR: The presence of high levels of the shed form of L-selectin (sL- selectin) in plasma from patients with acute leukemia and a functional role for sL- Selectin purified from leukemic plasma was supported by its ability to completely inhibit L-Selectin-dependent adhesion of blast cells to tumor necrosis factor-alpha (TNF-alpha)-activated endothelium in vitro.
66
Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
Pierre Vogt,Patrick Monnier,Marie-D. Schaller,Jean-J. Goy,Philippe Beuret,Axel Essinger,Fedor Bachmann,Jacques Hauert,Claude Perret,Ulrich Sigwart,Lukas Kappenberger +10 more
TL;DR: It is concluded that intravenous administration of anistreplase or streptokinase is efficient and safe in patients with acute myocardial infarction treated with 2 different intravenous thrombolytic agents.
9